drugset / Trial / NCT01998529

Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy

NCT01998529

Phase 1 Completed 7 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to find the highest tolerated dose of heated cisplatin that can be given to patients with lung tumors. The safety of this drug will also be studied.

Timeline

Start
2014-08-20
Primary completion
2020-08-25
Completion
2020-08-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 120 mg/m2 Other
Background amifostine Unknown Intravenous

Indications